Literature DB >> 16157953

The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease.

Tomohiko Sakatani1, Takeshi Shirayama, Yoko Suzaki, Taku Yamamoto, Hiroki Mani, Tatsuya Kawasaki, Hiroki Sugihara, Hiroaki Matsubara.   

Abstract

Hypercholesterolemia is a risk factor for development of coronary artery disease (CAD), however, several reports have suggested that low serum cholesterol is associated with a worse prognosis in patients with congestive heart failure (CHF). The objective of this study was to determine the prognostic value of cholesterol for CHF. The study subjects consisted of 133 consecutive patients hospitalized in our institution for progressive heart failure from April 2000 to March 2003. Thirty-two percent of the patients had CAD. After improvement of congestive heart failure and discharge from the hospital, lipid profiles, including serum total cholesterol (TC), triglycerides, and high and low density lipoprotein cholesterol (HDL, LDL, respectively), were obtained. During the follow-up period (2.3 +/- 0.9 years), 21 patients died. There was a significant difference between survivors and nonsurvivors in HDL (53 +/- 15, 43 +/- 15 mg/dL, P = 0.01), but no differences were observed in other variables. In patients with CAD, survivors had significantly lower TC concentrations (179 +/- 30 versus 246 +/- 55 mg/dL, P = 0.004), although in patients without CAD, survivors had significantly higher TC concentrations (203 +/- 37 versus 170 +/- 40 mg/dL, P = 0.02). Multivariate analysis showed high TC predicted a worse outcome in patients with CAD (odds ratio (OR) = 1.052, 95% confidence interval (CI) 1.002-1.104, P = 0.04), but a better outcome in patients without CAD (OR = 0.972, 95% CI 0.948-0.997, P = 0.03), independent of age, gender, medication, and complications. Thus, low serum cholesterol is associated with an improved outcome in patients with CAD, while it predicts a worse outcome in patients without CAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157953     DOI: 10.1536/ihj.46.619

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  7 in total

1.  Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?

Authors:  Alberico Luigi Catapano; Angela Pirillo; Giuseppe Danilo Norata
Journal:  Mol Ther       Date:  2017-10-19       Impact factor: 11.454

2.  Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathy.

Authors:  Parin J Patel; Amit V Khera; Robert L Wilensky; Daniel J Rader
Journal:  Eur J Heart Fail       Date:  2013-05-24       Impact factor: 15.534

3.  Association of total cholesterol and HDL-C levels and outcome in coronary heart disease patients with heart failure.

Authors:  Qin Zhao; Jianfei Li; Jin Yang; Rongshan Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Antidiabetic Activity and Chemical Composition of Sanbai Melon Seed Oil.

Authors:  Fang Wang; Haili Li; Hang Zhao; Ya Zhang; Pengcheng Qiu; Jie Li; Siwang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-02       Impact factor: 2.629

Review 5.  Epidemiology of Heart Disease of Uncertain Etiology: A Population Study and Review of the Problem.

Authors:  Alessandro Menotti; Paolo Emilio Puddu
Journal:  Medicina (Kaunas)       Date:  2019-10-14       Impact factor: 2.430

6.  Associations of high HDL cholesterol level with all-cause mortality in patients with heart failure complicating coronary heart disease.

Authors:  Anping Cai; Xida Li; Qi Zhong; Minming Li; Rui Wang; Yingcong Liang; Wenzhong Chen; Tehui Huang; Xiaohong Li; Yingling Zhou; Liwen Li
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Cuicui Xiao; Jiao Gong; Shuguang Zhu; Zhiwei Zhang; Sujuan Xi; Yutian Chong; Yusheng Jie; Qi Zhang
Journal:  BMC Gastroenterol       Date:  2020-06-15       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.